We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$63.8B
AUM Growth
+$3.93B
(+6.6%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
22.75%
Holding
3,125
New
60
Increased
388
Reduced
2,521
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$20M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$11.8M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$11.8M |
| 4 |
Caesars Entertainment
CZR
|
+$11.1M |
| 5 |
PROG Holdings
PRG
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$59.2M |
| 2 |
PPLI
People Inc
PPLI
|
+$24.6M |
| 3 |
CZR
Caesars Entertainment Corporation
CZR
|
+$19.1M |
| 4 |
Teradyne
TER
|
+$16.1M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.2% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 11.87% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Lemonade
LMND
$4.1B
| $516K | ﹤0.01% |
+10,373
| New | +$651K |
|
2277
Miller Industries
MLR
$619M
| $515K | ﹤0.01% |
16,832
-2,364
| -12% | -$71.2K |
|
2278
Black Diamond Therapeutics
BDTX
$112M
| $514K | ﹤0.01% |
17,019
+1,879
| +12% | +$57.2K |
|
2279
Cue Biopharma
CUE
$114M
| $514K | ﹤0.01% |
1,139
-57
| -5% | -$32.8K |
|
|
TDAY
2280
USA Today Co
TDAY
$1.06B
| $512K | ﹤0.01% |
393,612
-20,617
| -5% | -$31.4K |
|
|
ISEE
2281
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $511K | ﹤0.01% |
90,531
+27,352
| +43% | +$130K |
|
2282
Bally's
BALY
$658M
| $510K | ﹤0.01% |
19,406
-3,265
| -14% | -$75.9K |
|
2283
First Mid Bancshares
FMBH
$1.36B
| $510K | ﹤0.01% |
20,443
-3,099
| -13% | -$78.4K |
|
2284
Cato Corp
CATO
$66.1M
| $509K | ﹤0.01% |
65,149
-5,632
| -8% | -$44.2K |
|
2285
Arrow Financial
AROW
$652M
| $508K | ﹤0.01% |
22,107
-3,064
| -12% | -$76.1K |
|
2286
Axogen
AXGN
$2.5B
| $508K | ﹤0.01% |
43,723
-6,255
| -13% | -$72.6K |
|
|
CDMO
2287
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $502K | ﹤0.01% |
65,907
-9,265
| -12% | -$70.2K |
|
|
GHL
2288
DELISTED
Greenhill & Co., Inc.
GHL
| $502K | ﹤0.01% |
44,213
-2,378
| -5% | -$27.1K |
|
2289
Clean Energy Fuels
CLNE
$346M
| $501K | ﹤0.01% |
202,009
-31,487
| -13% | -$82K |
|
2290
Arcutis Biotherapeutics
ARQT
$3.18B
| $497K | ﹤0.01% |
16,975
+5,944
| +54% | +$159K |
|
2291
GrafTech
EAF
$212M
| $496K | ﹤0.01% |
7,257
+549
| +8% | +$38.3K |
|
2292
Construction Partners
ROAD
$6.77B
| $496K | ﹤0.01% |
27,248
+2,996
| +12% | +$53.7K |
|
2293
Regis Corp
RGS
$70.3M
| $495K | ﹤0.01% |
4,028
-213
| -5% | -$32.1K |
|
2294
Stoke Therapeutics
STOK
$2.11B
| $494K | ﹤0.01% |
14,762
-2,115
| -13% | -$60.4K |
|
2295
AMC Entertainment Holdings
AMC
$2.31B
| $493K | ﹤0.01% |
10,470
-1,200
| -10% | -$60.1K |
|
|
RNAM
2296
DELISTED
Avidity Biosciences
RNAM
| $493K | ﹤0.01% |
+17,516
| New | +$506K |
|
2297
AdaptHealth
AHCO
$759M
| $492K | ﹤0.01% |
+22,540
| New | +$473K |
|
2298
UroGen Pharma
URGN
$2.29B
| $492K | ﹤0.01% |
25,517
-3,570
| -12% | -$80.8K |
|
2299
Purple Innovation
PRPL
$41.7M
| $491K | ﹤0.01% |
789
+229
| +41% | +$122K |
|
|
ORC
2300
Orchid Island Capital
ORC
$1.31B
| $490K | ﹤0.01% |
19,569
-2,829
| -13% | -$70.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2020 Portfolio in Review
As of Q3 2020, RhumbLine Advisers held 3,125 positions worth $63.8B, up 6.6% from $59.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
RhumbLine Advisers's Q3 2020 filing shows 60 new, 388 increased, 2,521 reduced and 139 closed positions. Its largest new stake was PROG Holdings: 245,531 shares worth $11.8M. The largest sale was Apple, an estimated $59.2M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2020 buy was PROG Holdings: 245,531 shares worth $11.8M.
- RhumbLine Advisers added most to Match Group in Q3 2020, an estimated $20M increase.
- RhumbLine Advisers's biggest Q3 2020 reduction was Apple, cutting an estimated $59.2M.
- RhumbLine Advisers fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $19.1M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $63.8B portfolio in Q3 2020.
- RhumbLine Advisers opened 60 new positions and closed 139 in Q3 2020.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $63.8B.
Based on RhumbLine Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.